Apnimed, Inc.

NASDAQ:APMD

Biotechnology

Healthcare
$17.45 +2.84%

+$0.71 today

Market cap
$726.46M
Beta
0.00

Volume 0.30M

Average 1.15M

APMD Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

No reported Stock-Based Compensation figures are available to summarize.

Stock-Based Compensation history

Currency unavailable · from the cash flow

No Stock-Based Compensation data reported for this period type.

Stock-Based Compensation vs competitors

How APMD compares with its peers on the latest reported figures

APMD Competitors
Stock-Based Compensation for APMD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
INSPInspire Medical Systems, Inc.LTM Jun 2026$119.43M USD-8.2%+35.8%13.3%
NYXHNyxoah S.A.LTM Mar 2026€887K EUR-82.2%—5.4%
APMDApnimed, Inc.—— ———
Peer median (excluding APMD) —-45.2%+35.8%9.4%

Competitors are the stored peer set for APMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Apnimed, Inc.

NASDAQ:APMD

Intrinsic Alpha fair value

Locked

Current Price

$17.45

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.